COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population
High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots'...
Gespeichert in:
| Veröffentlicht in: | PloS one Jg. 16; H. 3; S. e0248892 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
24.03.2021
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights.
Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine.
Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated.
Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. |
|---|---|
| AbstractList | High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights. Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine. Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated. Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights.BACKGROUNDHigh levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights.Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine.METHODSRepresentative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine.Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated.RESULTSOverall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated.Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic.CONCLUSIONSOur findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. Background High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights. Methods Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine. Results Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated. Conclusions Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. BackgroundHigh levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights.MethodsRepresentative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine.ResultsOverall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated.ConclusionsOur findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights. Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine. Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated. Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. About the Authors: Ben Edwards Roles Conceptualization, Formal analysis, Methodology, Writing – original draft * E-mail: ben.edwards@anu.edu.au Affiliation: ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia ORCID logo https://orcid.org/0000-0001-6041-5054 Nicholas Biddle Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing Affiliation: ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia Matthew Gray Roles Conceptualization, Writing – review & editing Affiliation: ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia Kate Sollis Roles Writing – review & editing Affiliation: ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia ORCID logo https://orcid.org/0000-0002-0636-8805 Abstract Background High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. Conclusions Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic. The World Health Organisation’s Strategic Advisory Group of Experts (SAGE) have suggested governments take a proactive response to vaccine hesitancy ‘hotspots’ based on social and behavioural insights [11]. [...]nationally representative information is important for an agile response to COVID-19 vaccination. Given the Australian government has indicated that the COVID-19 vaccine would be provided free to the population, consistent with previous research on vaccine hesitancy [7, 13] we hypothesise that confidence in government and science, attitudes towards COVID-19 and adherence with public health messages, conservative and authoritarian political attitudes will be more important than demographic characteristics [7, 8, 13]. |
| Audience | Academic |
| Author | Edwards, Ben Sollis, Kate Gray, Matthew Biddle, Nicholas |
| AuthorAffiliation | National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, ITALY ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia |
| AuthorAffiliation_xml | – name: ANU Centre for Social Research and Methods, Australian National University, Melbourne, Australia – name: National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, ITALY |
| Author_xml | – sequence: 1 givenname: Ben orcidid: 0000-0001-6041-5054 surname: Edwards fullname: Edwards, Ben – sequence: 2 givenname: Nicholas surname: Biddle fullname: Biddle, Nicholas – sequence: 3 givenname: Matthew surname: Gray fullname: Gray, Matthew – sequence: 4 givenname: Kate orcidid: 0000-0002-0636-8805 surname: Sollis fullname: Sollis, Kate |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33760836$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11r2zAUhs3oWD-2fzA2wWBsF8lky7bsXgxK9hUoFPbRW3EsHyUqipRKclh-wP73lDQtTSlj9oWto-e80nk55zg7sM5ilr3M6ThnPP9w5QZvwYyXKTymRdk0bfEkO8pbVozqgrKDe_-H2XEIV5RWrKnrZ9khY7ymDauPsj-Ti8vpp1HekhVIqS2SOQYdwco1AdsTn1Zhs8RTMnHeo4GIgWhLgFiI2qUrmHXClolEG1NohcQ4O9Nx6HXaJWHwK1wTp0icIzkbQvRgNFiydMvBbDWeZ08VmIAvdt-T7NeXzz8n30bnF1-nk7PzkeRVE0dlzzCXXYtFoUqAhvdKsbLhCNih6qTiqmtAdVVfNx3lXHFoVVXwVmLRyR7YSfb6RndpXBA7B4MoKlpyXlYVTcT0hugdXIml1wvwa-FAi23A-ZkAH7U0KGSDErqWU2y7EnndoaSIDEreYEF5mbQ-7k4bugX2MtmTKt8T3d-xei5mbiV429KiaJLAu52Ad9cDhigWOkg0Biy6YXvvitVNzuqEvnmAPl7djppBKkBb5dK5ciMqzuqqzlnF0nOSjR-h0tvjQsvUbkqn-F7C-72ExET8HWcwhCCmP77_P3txuc--vcfOEUycB2eGTcuEffDVfafvLL7t8wSUN4D0LgSP6g7JqdiM061dYjNOYjdOKe30QZrUcduxyRFt_p38F9wCKiI |
| CitedBy_id | crossref_primary_10_1016_j_ipm_2022_103013 crossref_primary_10_1016_j_chaos_2021_111710 crossref_primary_10_1186_s12879_022_07111_0 crossref_primary_10_1080_03069885_2024_2304184 crossref_primary_10_1016_j_socscimed_2023_115865 crossref_primary_10_1371_journal_pone_0300191 crossref_primary_10_3390_vaccines10122041 crossref_primary_10_1002_oby_23182 crossref_primary_10_3390_vaccines9080900 crossref_primary_10_1017_dmp_2021_291 crossref_primary_10_2196_47099 crossref_primary_10_1371_journal_pone_0262823 crossref_primary_10_1371_journal_pone_0263375 crossref_primary_10_1016_j_vaccine_2021_07_006 crossref_primary_10_1080_10810730_2023_2236976 crossref_primary_10_3390_ijerph19159268 crossref_primary_10_1016_j_socscimed_2022_114800 crossref_primary_10_1111_hex_13405 crossref_primary_10_3390_vaccines10111933 crossref_primary_10_1007_s11482_022_10104_5 crossref_primary_10_1016_j_anzjph_2024_100128 crossref_primary_10_1111_1475_4932_12667 crossref_primary_10_1080_14760584_2022_2013819 crossref_primary_10_1080_21645515_2021_2017734 crossref_primary_10_1093_aje_kwab293 crossref_primary_10_1136_bmjph_2023_000642 crossref_primary_10_3389_fneur_2021_757038 crossref_primary_10_1513_AnnalsATS_202203_250VP crossref_primary_10_2196_37831 crossref_primary_10_1080_10410236_2023_2179711 crossref_primary_10_1007_s12508_021_00317_8 crossref_primary_10_1016_j_vaccine_2021_05_069 crossref_primary_10_1016_j_ijdrr_2022_103181 crossref_primary_10_1016_j_vaccine_2022_02_059 crossref_primary_10_3390_vaccines11010085 crossref_primary_10_3390_vaccines11040779 crossref_primary_10_1016_S1473_3099_21_00694_0 crossref_primary_10_3390_ijerph18178954 crossref_primary_10_5694_mja2_52551 crossref_primary_10_1016_j_jiph_2023_01_020 crossref_primary_10_1177_08969205231180267 crossref_primary_10_3390_vaccines9101141 crossref_primary_10_1007_s10865_022_00333_2 crossref_primary_10_1136_bmjopen_2022_061732 crossref_primary_10_1177_20551029241248757 crossref_primary_10_5694_mja2_52677 crossref_primary_10_1016_j_vaccine_2021_04_020 crossref_primary_10_1016_j_jfma_2024_05_006 crossref_primary_10_1080_14760584_2022_2019581 crossref_primary_10_3390_vaccines10101595 crossref_primary_10_1057_s41599_022_01185_6 crossref_primary_10_1016_j_vaccine_2022_05_012 crossref_primary_10_1071_AH22142 crossref_primary_10_3389_fpubh_2022_761987 crossref_primary_10_3390_vaccines9101153 crossref_primary_10_3390_vaccines10010122 crossref_primary_10_1186_s12884_023_05958_y crossref_primary_10_1016_j_hlpt_2024_100849 crossref_primary_10_7759_cureus_15922 crossref_primary_10_1002_hec_4693 crossref_primary_10_3390_vaccines10020161 crossref_primary_10_1038_s41598_022_26959_5 crossref_primary_10_1186_s42269_023_01017_w crossref_primary_10_2196_37775 crossref_primary_10_1002_jcop_22652 crossref_primary_10_3390_vaccines9060654 crossref_primary_10_3390_ijerph19052707 crossref_primary_10_1038_s41598_023_46864_9 crossref_primary_10_1111_phn_13134 crossref_primary_10_3389_fpubh_2022_977940 crossref_primary_10_1155_2023_5901128 crossref_primary_10_1136_fmch_2022_001692 crossref_primary_10_1007_s10389_021_01677_w crossref_primary_10_3390_vaccines11050907 crossref_primary_10_3390_vaccines11020411 crossref_primary_10_1016_j_japh_2022_01_014 crossref_primary_10_1371_journal_pone_0259513 crossref_primary_10_1080_20008198_2021_1997173 crossref_primary_10_1111_1475_6765_12749 crossref_primary_10_1177_09636625221138494 crossref_primary_10_3390_vaccines13050499 crossref_primary_10_1177_21582440251324763 crossref_primary_10_2147_RMHP_S368057 crossref_primary_10_3390_vaccines10010026 crossref_primary_10_3390_epidemiologia3010011 crossref_primary_10_1177_00469580231162524 crossref_primary_10_1186_s12889_021_12479_w crossref_primary_10_2217_fvl_2022_0028 crossref_primary_10_3389_fmed_2021_783982 crossref_primary_10_1071_AH23044 crossref_primary_10_1111_ssqu_13106 crossref_primary_10_1177_09636625211056871 crossref_primary_10_2196_48641 crossref_primary_10_3889_oamjms_2022_10586 crossref_primary_10_1016_j_chb_2022_107533 crossref_primary_10_1080_07853890_2023_2165705 crossref_primary_10_1371_journal_pone_0270666 crossref_primary_10_3389_fpubh_2023_1085197 crossref_primary_10_1016_j_hlpt_2022_100606 crossref_primary_10_3390_vaccines9060662 crossref_primary_10_1080_11287462_2024_2361968 crossref_primary_10_3390_soc14090191 crossref_primary_10_1016_j_hlpt_2021_100540 crossref_primary_10_1177_07334648231225341 crossref_primary_10_1002_smi_3255 crossref_primary_10_1177_10105395221100805 crossref_primary_10_3390_vaccines9080936 crossref_primary_10_3390_vaccines9080814 crossref_primary_10_1080_01296612_2021_1921963 crossref_primary_10_1057_s41285_023_00201_2 crossref_primary_10_1080_24750158_2022_2135360 crossref_primary_10_1371_journal_pone_0279481 crossref_primary_10_3390_vaccines9101113 crossref_primary_10_1007_s40615_022_01236_3 crossref_primary_10_1016_j_joim_2021_10_004 crossref_primary_10_1186_s12889_022_14261_y crossref_primary_10_1371_journal_pone_0254920 crossref_primary_10_7759_cureus_40626 crossref_primary_10_2174_0118749445298070240319081623 crossref_primary_10_1016_j_jort_2021_100445 crossref_primary_10_1017_S000842392300015X crossref_primary_10_1111_birt_12741 crossref_primary_10_3390_vaccines9121498 crossref_primary_10_1093_tbm_ibac056 crossref_primary_10_1371_journal_pone_0303854 crossref_primary_10_1111_1754_9485_13345 crossref_primary_10_1186_s12884_022_04884_9 crossref_primary_10_1371_journal_pone_0273555 crossref_primary_10_3390_vaccines10111775 crossref_primary_10_1080_10810730_2023_2181891 crossref_primary_10_3390_vaccines10101739 crossref_primary_10_1071_PY21165 crossref_primary_10_1177_00243639231178626 crossref_primary_10_1016_j_puhe_2022_01_015 crossref_primary_10_2147_PPA_S338932 crossref_primary_10_3390_vaccines10111893 crossref_primary_10_3390_vaccines9080876 crossref_primary_10_2188_jea_JE20210458 crossref_primary_10_3390_vaccines9080873 crossref_primary_10_3390_vaccines11010132 crossref_primary_10_1136_bmjopen_2021_059411 crossref_primary_10_1186_s13584_022_00527_8 crossref_primary_10_1016_j_heliyon_2023_e23408 crossref_primary_10_32604_cmc_2022_027630 crossref_primary_10_1016_j_heliyon_2022_e10728 crossref_primary_10_1093_pnasnexus_pgad146 crossref_primary_10_1080_10410236_2022_2054102 crossref_primary_10_2139_ssrn_3803323 crossref_primary_10_2196_33995 crossref_primary_10_1038_s41562_022_01431_6 crossref_primary_10_12688_wellcomeopenres_17517_1 crossref_primary_10_1007_s11089_024_01147_6 crossref_primary_10_1111_ajr_13047 crossref_primary_10_1177_17579759231174750 crossref_primary_10_3390_vaccines12060627 crossref_primary_10_1002_ajs4_220 crossref_primary_10_1016_j_nurpra_2024_105113 crossref_primary_10_1016_j_bbih_2022_100448 crossref_primary_10_1080_21645515_2021_1993689 crossref_primary_10_3390_vaccines10020209 crossref_primary_10_1080_01612840_2021_1923971 crossref_primary_10_3390_vaccines9111225 crossref_primary_10_3390_vaccines10030470 crossref_primary_10_1136_bmjopen_2021_055034 crossref_primary_10_1080_13501763_2022_2123024 crossref_primary_10_3390_data6110112 crossref_primary_10_3390_vaccines11081332 crossref_primary_10_1186_s12889_021_12196_4 crossref_primary_10_1089_heq_2021_0171 crossref_primary_10_1093_heapro_daac192 crossref_primary_10_3390_vaccines9121384 crossref_primary_10_3390_su142315764 crossref_primary_10_1186_s12889_023_16600_z crossref_primary_10_1111_ajo_13622 crossref_primary_10_3928_24748307_20230621_01 crossref_primary_10_4274_jpr_galenos_2023_00878 crossref_primary_10_1136_bcr_2021_246580 crossref_primary_10_1371_journal_pone_0289678 crossref_primary_10_1002_casp_70088 crossref_primary_10_3390_ijerph191811729 crossref_primary_10_3390_ijerph19063202 crossref_primary_10_3390_healthcare9101353 crossref_primary_10_3390_ijerph19159507 crossref_primary_10_1016_j_annemergmed_2022_01_040 crossref_primary_10_1080_21645515_2022_2072144 crossref_primary_10_1017_gov_2023_35 crossref_primary_10_1017_dmp_2023_147 crossref_primary_10_1177_02633957211061999 crossref_primary_10_3390_vaccines10020222 crossref_primary_10_1111_tid_13749 crossref_primary_10_1016_j_heliyon_2024_e24826 crossref_primary_10_1038_s41598_022_16572_x crossref_primary_10_3390_vaccines10050657 crossref_primary_10_1177_19401612241302755 crossref_primary_10_4236_health_2022_141003 crossref_primary_10_2196_33909 crossref_primary_10_1136_bmjgh_2021_008271 crossref_primary_10_1080_21645515_2022_2050105 crossref_primary_10_2989_16085906_2022_2118615 crossref_primary_10_1108_JSOCM_01_2024_0006 crossref_primary_10_3389_fpubh_2024_1382849 crossref_primary_10_1371_journal_pone_0294480 crossref_primary_10_1080_21645515_2022_2079345 crossref_primary_10_1016_j_vaccine_2024_04_069 crossref_primary_10_1007_s10943_021_01466_5 crossref_primary_10_1016_j_healthpol_2023_104858 crossref_primary_10_1136_bmjopen_2023_080733 crossref_primary_10_1371_journal_pone_0323849 crossref_primary_10_3390_ijerph21030331 crossref_primary_10_2174_0126667975286678240303150814 crossref_primary_10_2147_JMDH_S347669 crossref_primary_10_1007_s10754_024_09373_4 crossref_primary_10_3390_jcm10225338 crossref_primary_10_2196_37806 crossref_primary_10_3390_vaccines10111872 crossref_primary_10_1016_j_socscimed_2023_115779 crossref_primary_10_1016_j_puhip_2022_100349 crossref_primary_10_1080_21645515_2021_2025008 crossref_primary_10_1016_j_cegh_2022_101182 crossref_primary_10_5694_mja2_51136 crossref_primary_10_1108_K_06_2022_0810 crossref_primary_10_1007_s10461_022_03603_x crossref_primary_10_1177_00099228241281126 crossref_primary_10_3390_vaccines9121467 |
| Cites_doi | 10.1016/j.pec.2018.08.027 10.1016/j.amepre.2020.06.011 10.3201/eid2607.200282 10.1080/21645515.2018.1564437 10.1016/j.vaccine.2015.04.034 10.1016/j.arr.2020.101118 10.1038/s41562-020-0906-x 10.1038/s41467-020-20226-9 10.1586/14760584.2015.964212 10.1056/NEJMp2020926 10.1007/s10198-020-01208-6 10.1016/j.vaccine.2020.08.043 10.1016/j.immuni.2020.04.012 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 Public Library of Science 2021 Edwards et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Edwards et al 2021 Edwards et al |
| Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Edwards et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Edwards et al 2021 Edwards et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0248892 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & allied health premium. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central - New (Subscription) ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Public Health |
| DocumentTitleAlternate | COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2504774550 oai_doaj_org_article_c8ecab970e9b4e76bec0ee3a478e2074 PMC7990228 A656135333 33760836 10_1371_journal_pone_0248892 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Australia United Kingdom--UK Melbourne Victoria Australia |
| GeographicLocations_xml | – name: Australia – name: United Kingdom--UK – name: Melbourne Victoria Australia |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAIFH BAWUL BBNVY BBTPI BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ ALIPV BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K COVID DWQXO ESTFP FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c758t-4d3e1cb9e22f4aa87dff3487eaebefbcf7fb8afb5d68b077f7a9f5279ce2bcda3 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 252 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000633030400046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Fri Nov 26 17:12:37 EST 2021 Tue Oct 14 19:06:31 EDT 2025 Tue Nov 04 02:01:34 EST 2025 Sun Nov 09 11:58:46 EST 2025 Tue Oct 07 08:07:57 EDT 2025 Sat Nov 29 12:59:42 EST 2025 Sat Nov 29 10:08:44 EST 2025 Wed Nov 26 09:33:04 EST 2025 Wed Nov 26 10:02:13 EST 2025 Thu May 22 21:21:31 EDT 2025 Wed Feb 19 02:07:12 EST 2025 Tue Nov 18 22:02:56 EST 2025 Sat Nov 29 01:45:45 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c758t-4d3e1cb9e22f4aa87dff3487eaebefbcf7fb8afb5d68b077f7a9f5279ce2bcda3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0001-6041-5054 0000-0002-0636-8805 |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pone.0248892 |
| PMID | 33760836 |
| PQID | 2504774550 |
| PQPubID | 1436336 |
| PageCount | e0248892 |
| ParticipantIDs | plos_journals_2504774550 doaj_primary_oai_doaj_org_article_c8ecab970e9b4e76bec0ee3a478e2074 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7990228 proquest_miscellaneous_2505368136 proquest_journals_2504774550 gale_infotracmisc_A656135333 gale_infotracacademiconefile_A656135333 gale_incontextgauss_ISR_A656135333 gale_incontextgauss_IOV_A656135333 gale_healthsolutions_A656135333 pubmed_primary_33760836 crossref_primary_10_1371_journal_pone_0248892 crossref_citationtrail_10_1371_journal_pone_0248892 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-24 |
| PublicationDateYYYYMMDD | 2021-03-24 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-24 day: 24 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2021 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | P. L. Reiter (pone.0248892.ref006) 2020; 38 pone.0248892.ref014 S. Sanche (pone.0248892.ref003) 2020; 26 J Demurtas (pone.0248892.ref017) 2020; 62 T. Hale (pone.0248892.ref015) 2020 MM Mello (pone.0248892.ref020) 2020; 383 E Dubé (pone.0248892.ref012) 2015; 14 M. R. Gualano (pone.0248892.ref019) 2019; 15 Sydney Health Literacy Lab COVID-19 group (pone.0248892.ref010) 2020 N. Biddle (pone.0248892.ref021) 2020 S. Neumman-Bohme (pone.0248892.ref005) 2020; 21 L Thunström (pone.0248892.ref013) 2020; 35 B Hickler (pone.0248892.ref011) 2015; 34 S. M. Bartsch (pone.0248892.ref004) 2020; 59 S. M. Sherman (pone.0248892.ref008) 2020 S. Yadav (pone.0248892.ref001) T Rozbroj (pone.0248892.ref016) 2019; 102 pone.0248892.ref009 J. Murphy (pone.0248892.ref007) 2021; 12 H Randolph (pone.0248892.ref002) 2020; 52 K. B. Habersaat (pone.0248892.ref018) 2020; 4 |
| References_xml | – volume: 102 start-page: 172 issue: 1 year: 2019 ident: pone.0248892.ref016 article-title: Psychosocial and demographic characteristics relating to vaccine attitudes in Australia publication-title: Patient education and counselling doi: 10.1016/j.pec.2018.08.027 – year: 2020 ident: pone.0248892.ref010 article-title: Willingness to vaccinate against COVID-19 in Australia. publication-title: Lancet Infect Dis – volume: 59 start-page: 493 issue: 4 year: 2020 ident: pone.0248892.ref004 article-title: Vaccine efficacy needed for a COVID-19 Coronavirus vaccine to prevent or stop an epidemic as the sole intervention. publication-title: American Journal of Preventive Medicine doi: 10.1016/j.amepre.2020.06.011 – volume: 26 start-page: 1470 issue: 7 year: 2020 ident: pone.0248892.ref003 article-title: High contagiousness and rapid spread of severe acute respiratory syndrome Coronavirus 2 publication-title: Emerging Infectious Diseases doi: 10.3201/eid2607.200282 – year: 2020 ident: pone.0248892.ref008 article-title: COVID-19 vaccination intention in the UK: Results from the ‘COVID-19 Vaccination Acceptability Study’ (CoVAccS), a nationally representative cross-sectional survey. publication-title: Human Vaccines & Immunotherapeutics – ident: pone.0248892.ref014 – ident: pone.0248892.ref009 – volume: 15 start-page: 918 issue: 4 year: 2019 ident: pone.0248892.ref019 article-title: Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. publication-title: Human Vaccines & Immunotherapeutics doi: 10.1080/21645515.2018.1564437 – volume: 34 start-page: 4155 issue: 33 year: 2015 ident: pone.0248892.ref011 article-title: Vaccine special issue on vaccine hesitancy publication-title: Vaccine doi: 10.1016/j.vaccine.2015.04.034 – volume: 62 start-page: 101118 year: 2020 ident: pone.0248892.ref017 article-title: The efficacy and safety of influenza vaccination in older people: An umbrella review of evidence from meta-analyses of both observational and randomized controlled studies. publication-title: Ageing Res Rev. doi: 10.1016/j.arr.2020.101118 – volume: 4 start-page: 677 year: 2020 ident: pone.0248892.ref018 article-title: Ten considerations for effectively managing the COVID-19 transition. publication-title: Nature Human Behaviour doi: 10.1038/s41562-020-0906-x – year: 2020 ident: pone.0248892.ref015 article-title: Oxford COVID-19 Government Response Tracker, Blavatnik School of Government – volume: 35 start-page: 7 year: 2020 ident: pone.0248892.ref013 article-title: Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity publication-title: Covid Economics – volume: 12 start-page: 29 year: 2021 ident: pone.0248892.ref007 article-title: Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. publication-title: Nature Communications doi: 10.1038/s41467-020-20226-9 – year: 2020 ident: pone.0248892.ref021 article-title: Public attitudes on vaccine distribution publication-title: Centre for Social Research and Methods (ANU) – volume: 14 start-page: 100 issue: 1 year: 2015 ident: pone.0248892.ref012 article-title: Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. publication-title: Expert Reviews Vaccines doi: 10.1586/14760584.2015.964212 – volume: 383 start-page: 1296 year: 2020 ident: pone.0248892.ref020 article-title: Ensuring uptake of vaccines against SARSCoV-2 publication-title: N Engl J Med doi: 10.1056/NEJMp2020926 – volume: 21 start-page: 977 year: 2020 ident: pone.0248892.ref005 article-title: Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 publication-title: The European Journal of Health Economics doi: 10.1007/s10198-020-01208-6 – ident: pone.0248892.ref001 article-title: Basic reproduction rate and case fatality rate of COVID-19: Application of meta-analysis. publication-title: medRxiv – volume: 38 start-page: 6500 issue: 42 year: 2020 ident: pone.0248892.ref006 article-title: Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? publication-title: Vaccine doi: 10.1016/j.vaccine.2020.08.043 – volume: 52 start-page: 737 year: 2020 ident: pone.0248892.ref002 article-title: Herd immunity: understanding COVID-19 publication-title: Immunity doi: 10.1016/j.immuni.2020.04.012 |
| SSID | ssj0053866 |
| Score | 2.6959467 |
| Snippet | High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of... Background High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop... BackgroundHigh levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop... About the Authors: Ben Edwards Roles Conceptualization, Formal analysis, Methodology, Writing – original draft * E-mail: ben.edwards@anu.edu.au Affiliation:... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0248892 |
| SubjectTerms | Adult Aged Aged, 80 and over Attitudes Australia - epidemiology Biology and Life Sciences Confidence Coronaviruses Correlation analysis COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 - psychology COVID-19 vaccines COVID-19 Vaccines - administration & dosage Demographics Disease hot spots Editing Epidemics Female Health attitudes Health Knowledge, Attitudes, Practice Humans Longitudinal Studies Male Medicine and Health Sciences Methods Middle Aged Pandemics Pandemics - prevention & control Patient Acceptance of Health Care - psychology Patient Acceptance of Health Care - statistics & numerical data Political attitudes Politics Population Public health Public Health - trends Research and Analysis Methods Reviews SARS-CoV-2 - immunology Social behavior Social research Social Sciences Surveys Surveys and Questionnaires - statistics & numerical data Vaccination Vaccination - statistics & numerical data Vaccination Refusal - psychology Vaccination Refusal - statistics & numerical data Vaccine hesitancy Vaccines Viral diseases |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQigMXRHk1pYBBSMAhbWInccytLFRUQi3iseotsh2brrRKVpvNSv0B_G9mEm9oUKVy4BqPN9mZ8TySmW8IeRXFKrdgEkMBxj9MykSE4ARlKJRKU6bB43Zd_LPP4vQ0Pz-XX66M-sKasB4euGfcocmtUVqKyEqdWJHBPSNruUoE3AP8H1rfSMhtMtXbYDjFWeYb5biID71cDpZ1ZQ8QxSuXbOSIOrz-wSpPlou6uS7k_Lty8oorOr5H7voYkh71z75DbtnqPtnxp7ShbzyU9NsH5Nf0bHbyIYwl3SiDn9DpBc4BQItKVVVSyLUxfoRt7-gU53QsMPSk84oqun1NuLikHfKl71LaWLqocchRW-JALdq0q429pLWjEErSP69O6HIYDfaQ_Dj--H36KfSDF0ID6cMaRMZtbLS0jLlEqVyUznHIbKwCkTttnHA6V06nZZbrSAgnlHQpE9JYpk2p-CMyqYDVu4TqSEtmlbAQhoEfTFWUuMhmJcR5GXOMBYRvpVAYj0qOwzEWRfepTUB20jO1QNkVXnYBCYddyx6V4wb69yjggRYxtbsLoGmF17TiJk0LyHNUj6JvUB0sQ3GUYRIGYTMPyMuOAnE1Kizc-anapilOzmb_QPTt64jotSdyNbDDKN8sAf8J8bpGlPsjSrAOZrS8i8q85UpTIGQdhPyQmMLOrYJfv_xiWMYfxWK8ytZtR5PyLI95FpDH_XkYOMuxyCrHFTE6KSPWj1eq-UUHay4gMGIs3_sfsnpC7jAsPop4yJJ9MlmvWvuU3Dab9bxZPetsxW_J5nPE priority: 102 providerName: Directory of Open Access Journals – databaseName: Nursing & allied health premium. dbid: 7RV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELVg4YCEgJaPLhQwCAk4pE3sJE64oLJQUQm1qMCqt8h27HalVbJsNiv1B_C_mUmclKAKkLjG4yixZ8bP9swbQl74gUwMuERPgPP3wjwUHiyCqSekjCKmYMVtsvinn8ThYXJykn52B26VC6vsfGLjqPNS4xn5LlJtAVQBQP128d3DqlF4u-pKaFwl1wLExqDP4njaeWKw5Th26XJcBLtudnYWZWF2kMsrSdlgOWpY-3vfPFrMy-oy4Pl7_OQvC9L-7f_9lTvkloOidK_VnQ1yxRSb5GZ7jkfb9KRNsuGMv6KvHEP167vkx-RoevDeC1K6lhpv5ukZlhdAR01lkVPYwiMshW5v6ATLf8wR0dJZQSXtTh_n57Qh1HTJT2tD5yXWTqpzrNNFq3q5Nue0tBQQKr04kaGLvuLYPfJt_8PXyUfP1XPwNOxKVqAJ3ARapYYxG0qZiNxaDhsmI0GTrNJWWJVIq6I8TpQvhBUytRETqTZM6Vzy-2RUwNxtEap8lTIjhQF0B8trJP3Q-ibOAT7GzDI2Jryb1kw7snOsuTHPmhs8AZuedpAzVIbMKcOYeH2vRUv28Rf5d6gxvSxSdTcPyuVp5iw_04nRUqXCN6kKjYjBaHxjuAwFGAkAuDF5ivqWtXmvvcPJ9mLc2wEa52PyvJFAuo4C44FOZV1V2cHR9B-EvhwPhF46IVvCcGjpcjDgn5AGbCC5PZAEp6MHzVtoHd2oVNmFTkPPTusvb37WN-NLMcavMGXdyEQ8TgIej8mD1sD6keUYu5VgixiY3mDohy3F7KxhSxeAtxhLHv75sx6RGwyjlXzusXCbjFbL2jwm1_V6NauWTxq38hPGCYWb priority: 102 providerName: ProQuest |
| Title | COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33760836 https://www.proquest.com/docview/2504774550 https://www.proquest.com/docview/2505368136 https://pubmed.ncbi.nlm.nih.gov/PMC7990228 https://doaj.org/article/c8ecab970e9b4e76bec0ee3a478e2074 http://dx.doi.org/10.1371/journal.pone.0248892 |
| Volume | 16 |
| WOSCitedRecordID | wos000633030400046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELeg4wEJARsfK4xiEBLwkJI4H054W8smqm1d1LGq8BI5js0qVUnVtJX2B_B_c5ekGZk2AS_3EJ-j5Ow739m-3xHyzrSEr8AkGhyMv-EkDjdgEQwMLoTrshhW3CKLf3zMh0N_MgnCq0Dx2gm-za1PlUy78yxVXUTg8gMwuVvM9jwMtg7D443lBd31vCo97raejeWnQOmvbXFrPsvymxzN6_cl_1iADh_976c_Jg8rV5Pul3Njm9xR6Q55UO7T0TL9aIdsV8qd0w8VAvXHJ-RX_3Q8-GJYAV0LiSfv9ALLB6AhpiJNKITo6HZCt8-0j-U9Zuix0mlKBd3sLs4uaQGYWSU3rRWdZVgbaZVgHS6arxZrdUkzTcEDpVc7LnReVxR7Ss4PD771vxpVvQZDQtSxhJG2lSXjQDGmHSF8nmhtQ0CkBMwUHUvNdewLHbuJ58cm55qLQLuMB1KxWCbCfkZaKYhql9DYjAOmBFfgvcHy6QrT0abyEnAPPaYZaxN7M4yRrMDMsabGLCpO6DgENaWQI5R9VMm-TYy617wE8_gLfw9nSM2LUNzFAxjkqNLsSPpKijjgpgpiR3EPlMJUyhYOByUAB61NXuP8isq81tqgRPsexm7gbdtt8rbgQDiOFO_7_BSrPI8Gp-N_YDobNZjeV0w6A3FIUeVYwD8hzFeDc6_BCUZFNpp3URs2UskjRLqDSAHiWei50ZCbm9_UzfhSvMOXqmxV8Li251u21ybPS4WqJWvj3SwfW3hD1Rqib7ak04sCDZ2DP8WY_-L2L35J7jO8iWTaBnP2SGu5WKlX5J5cL6f5okPu8tEY6YQX1Afq960O2eodDMNRp9il6RSGBuhRrwv0xDxCysOCngEN3R_QIxychN9_A-u_gHE |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEF2VgAQSAlouDRS6IBDw4NZZX9ZGQqikVI0a2gpKVPFi1uvdNlJkhzgJygfwO3wjM_baxagCXvrAY7JjK57MnDm7ngshT-2OCBRAosUB_C03cbkFQTC0uBCex2KIuEUV_6DP9_eD4-PwcIn8qGphMK2ywsQCqJNM4hn5JrbaAqoChPrN-KuFU6Pw7Wo1QqM0iz21-AZbtvx1bxv-32eM7bw76u5aZqqAJYEbT-H3OKoj41Axpl0hAp5o7QBtVwKeR8dScx0HQsde4gexzbnmItQe46FULJaJcOC-l8hl12U2etGh97lCfsAO3zfleQ7vbBpr2BhnqdrA3mFByBrhr5gSUMeC1niU5ecR3d_zNX8JgDs3_zfV3SI3DNWmW6VvLJMlla6Q6-U5JS3Lr1bIsgG3nL4wHbhf3ibfuweD3rbVCelcSMw8oKc4PgEDERVpQifwCVm1VK9oF8ebjJCx02FKBa1OV0cLWjQMNcVdc0VHGc6GmiU4h4zms8lcLWimKTBwenbiRMf1RLU75NOFqOcuaaVgK6uExnYcMiW4AvYK9METtqtt5SdAj32mGWsTpzKjSJpm7jhTZBQVbyg5bOpKJUdofJExvjax6qvGZTOTv8i_RQutZbEVefFFNjmJDLJFMlBSxCG3VRi7ivsACrZSjnA5gAAQ1DZZR_uOyrreGlCjLR_3rrDbcNrkSSGB7UhSzHc6EbM8j3oHg38Q-vihIfTcCOkM1CGFqTGBZ8I2Zw3JtYYkgKpsLK-iN1ZayaMzH4IrKy87f_lxvYw3xRzGVGWzQsZz_KDj-G1yr3ToWrMO5qYFuMIbrt5QfXMlHZ4W3eA58EnGgvt__lnr5Oru0ft-1O_t7z0g1xhmZtmOxdw10ppOZuohuSLn02E-eVRAGiVfLhoIfgKDFelL |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEF2VgBASAlouDRS6IBDw4NZZX9ZGQqg0VESt0qhAVPFi1uvdNlJkhzgJygfwU3wdM_baxagCXvrAY7JjK57MnDm7ngshT-2OCBRAosUB_C03cbkFQTC0uBCex2KIuEUV__CA9_vB8XE4WCE_qloYTKusMLEA6iSTeEa-ja22gKpgV21t0iIG3b03k68WTpDCN63VOI3SRPbV8hts3_LXvS78188Y23v3cfe9ZSYMWBJ48gx-m6M6Mg4VY9oVIuCJ1g5QeCXg2XQsNddxIHTsJX4Q25xrLkLtMR5KxWKZCAfue4lc5rDHxHTCgfe5igKAI75vSvUc3tk2lrE1yVK1hX3EgpA1QmExMaCOC63JOMvPI72_527-Egz3bv7ParxFbhgKTndKn1klKypdI9fL80talmWtkVUDejl9YTpzv7xNvu8eDntdqxPShZCYkUBPcawCBigq0oRO4ROybale0V0cezJGJk9HKRW0OnUdL2nRSNQUfS0UHWc4M2qe4Hwyms-nC7WkmabAzOnZSRSd1JPW7pBPF6Keu6SVgt2sExrbcciU4ApYLdAKT9iutpWfAG32mWasTZzKpCJpmrzjrJFxVLy55LDZK5UcoSFGxhDbxKqvmpRNTv4i_xattZbFFuXFF9n0JDKIF8lASRGH3FZh7CruA1jYSjnC5QAOQFzbZBNtPSrrfWugjXZ83NPCLsRpkyeFBLYpSdFST8Q8z6Pe4fAfhD4cNYSeGyGdgTqkMLUn8EzY_qwhudGQBLCVjeV19MxKK3l05k9wZeVx5y8_rpfxppjbmKpsXsh4jh90HL9N7pXOXWvWwZy1AFd4w-0bqm-upKPToks8B57JWHD_zz9rk1wF_48Oev39B-Qaw4Qt27GYu0Fas-lcPSRX5GI2yqePCnSj5MtF48BP_VHyFQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+vaccine+hesitancy+and+resistance%3A+Correlates+in+a+nationally+representative+longitudinal+survey+of+the+Australian+population&rft.jtitle=PloS+one&rft.au=Edwards%2C+Ben&rft.au=Biddle%2C+Nicholas&rft.au=Gray%2C+Matthew&rft.au=Sollis%2C+Kate&rft.date=2021-03-24&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=16&rft.issue=3&rft.spage=e0248892&rft_id=info:doi/10.1371%2Fjournal.pone.0248892&rft.externalDocID=A656135333 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |